Preventing lung cancer requires a combination of lifestyle, environmental, and clinical measures aimed at reducing exposure to known risk factors and promoting early detection. Tobacco use remains the single largest contributor to lung cancer, making smoking cessation programs a cornerstone of prevention. These programs include counseling, pharmacologic aids, nicotine replacement therapy, and public awareness campaigns to discourage initiation and support cessation. In addition, minimizing exposure to secondhand smoke, occupational carcinogens such as asbestos or diesel fumes, and environmental pollutants is essential to lower risk. Genetic predisposition and pre-existing lung conditions also influence individual susceptibility, highlighting the need for personalized prevention approaches.
Screening and early detection play a vital role in preventing advanced disease. Low-dose computed tomography (LDCT) screening in high-risk populations allows for identification of early-stage lung cancers that can be treated more effectively, improving survival rates. Public health initiatives, including education about symptom awareness and regular health check-ups, support timely medical evaluation. Lifestyle interventions such as maintaining a balanced diet rich in fruits and vegetables, engaging in regular physical activity, and managing chronic respiratory conditions further contribute to lowering risk. At the policy level, regulatory measures to control air pollution, enforce workplace safety, and reduce tobacco availability are critical. Comprehensive lung cancer prevention strategies integrate individual behavior modification, community health initiatives, and policy enforcement to reduce incidence, promote early diagnosis, and enhance overall population respiratory health
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation